DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cerubidine (Daunorubicin) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (22)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cerubidine side effects in 68 year old male

Reported by a physician from Switzerland on 2012-04-24

Patient: 68 year old male

Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Tazobactam
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-12
    End date: 2005-03-04

Cerubidine
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Methotrexate Sodium
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Oncovin
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Cyclophosphamide
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Valtrex
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Asparaginase
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Fungizone
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-01
    End date: 2005-02-01

Vfend
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Other drugs received by patient: Bactrim; Prednisone; Navoban; Torsemide



Possible Cerubidine side effects in 68 year old male

Reported by a physician from Switzerland on 2012-02-10

Patient: 68 year old male

Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Valtrex
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Oncovin
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Cerubidine
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Methotrexate Sodium
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Asparaginase
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Fungizone
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-01
    End date: 2005-02-01

Cyclophosphamide
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Tazobactam
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-12
    End date: 2005-03-04

Vfend
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Other drugs received by patient: Prednisone; Torsemide; Bactrim; Navoban



Possible Cerubidine side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-16

Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Sepsis, Generalised Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gleevec
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-01

Kidrolase
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Methotrexate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine Sulfate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Cerubidine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Aplasia, Stomatococcal Infection, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Spleen Disorder, Oral Disorder, Sepsis, Hypoxia, Acute Respiratory Distress Syndrome, Pleural Effusion, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Generalised Oedema, Ascites, Pericardial Effusion, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06

Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13



Possible Cerubidine side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-05

Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Sepsis, Generalised Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gleevec
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cerubidine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Cytarabine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Kidrolase
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cyclophosphamide
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-01

Vincristine Sulfate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-02

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Ascites, Pericardial Effusion, Generalised Oedema, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-31

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Oral Disorder, Sepsis, Pleural Effusion, Hypoxia, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14



Possible Cerubidine side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-14

Patient: 50 year old male

Reactions: White Blood Cell Count Decreased, Brain Stem Haemorrhage, Coma, Brain Abscess, Bone Marrow Failure, Vertigo, Cardiac Arrest, Thrombocytopenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-14

Patient: 57 year old male

Reactions: Septic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 50 year old female

Reported by a physician from France on 2011-11-11

Patient: 50 year old female

Reactions: Pituitary Infarction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gemtuzumab Ozogamicin
    Dosage: 6 mg/m2, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-05-25
    End date: 2010-05-25

Cytarabine
    Dosage: 200 mg/m2, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-05-22
    End date: 2010-05-28

Cerubidine
    Dosage: 60 mg/m2, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-05-22
    End date: 2010-05-24



Possible Cerubidine side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24

Patient: 56 year old male

Reactions: Cytolytic Hepatitis, Coagulation Factor V Level Decreased, Renal Failure, Dialysis, Venoocclusive Liver Disease, Platelet Count Decreased, Febrile Bone Marrow Aplasia, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 56 year old male

Reported by a physician from France on 2011-10-24

Patient: 56 year old male

Reactions: Renal Failure, Dialysis, Venoocclusive Liver Disease, Cytolytic Hepatitis, Febrile Bone Marrow Aplasia, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg/m2, 1x/day, intravenous
    Indication: Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-19

Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)
    Dosage: 6 mg/m2, 1x/day, intravenous
    Indication: Acute Leukaemia
    Start date: 2010-08-16
    End date: 2010-08-16

Cerubidine
    Dosage: 60 mg/m2, 1x/day, intravenous
    Indication: Acute Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-15

Other drugs received by patient: Amlodipine Besylate; Valsartan and Hydrochlorothiazide



Possible Cerubidine side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24

Patient: 56 year old male

Reactions: White Blood Cell Count Decreased, Blood Alkaline Phosphatase Increased, Alanine Aminotransferase Increased, Coagulation Factor V Level Decreased, Venoocclusive Disease, Renal Failure, Gamma-Glutamyltransferase Increased, Dialysis, Aspartate Aminotransferase Increased, Febrile Bone Marrow Aplasia, Platelet Count Decreased, Klebsiella Test Positive, Septic Shock, Immunosuppression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 37 year old male

Reported by a physician from France on 2011-10-24

Patient: 37 year old male

Reactions: Septic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cerubidine
    Dosage: 60 mg/m2, 1x/day, intravenous
    Indication: Acute Leukaemia
    Start date: 2010-06-08
    End date: 2010-06-10

Cytarabine
    Dosage: 200 mg/m2, 1x/day, intravenous
    Indication: Leukaemia
    Start date: 2010-06-08
    End date: 2010-06-12



Possible Cerubidine side effects in 37 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24

Patient: 37 year old male

Reactions: Septic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 56 year old male

Reported by a physician from France on 2011-10-24

Patient: 56 year old male

Reactions: Blood Alkaline Phosphatase Increased, Alanine Aminotransferase Increased, Coagulation Factor V Level Decreased, Renal Failure, Gamma-Glutamyltransferase Increased, Dialysis, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Febrile Bone Marrow Aplasia, Klebsiella Test Positive, Septic Shock, Immunosuppression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)
    Dosage: 6 mg/m2, 1x/day, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-16
    End date: 2010-08-16

Cytarabine
    Dosage: 200 mg/m2, 1x/day, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-19

Cerubidine
    Dosage: 60 mg/m2, 1x/day, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-15



Possible Cerubidine side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-14

Patient: 60 year old female

Reactions: Renal Failure, Disseminated Intravascular Coagulation, Cytolytic Hepatitis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 60 year old female

Reported by a physician from France on 2011-10-14

Patient: 60 year old female

Reactions: Renal Failure, Disseminated Intravascular Coagulation, Cytolytic Hepatitis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, 2x/day, intravenous
    Indication: Leukaemia
    Start date: 2010-04-21
    End date: 2010-04-22

Cerubidine
    Dosage: 60 mg/m2, 1x/day, intravenous
    Indication: Leukaemia
    Start date: 2010-04-21
    End date: 2010-04-23

Ambisome
    Dosage: 180 mg, 1x/day, intravenous
    Start date: 2010-04-21
    End date: 2010-04-22



Possible Cerubidine side effects in 50 year old female

Reported by a physician from France on 2011-10-14

Patient: 50 year old female

Reactions: Pituitary Infarction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gemtuzumab Ozogamicin
    Dosage: 6 mg/m2, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-05-25
    End date: 2010-05-25

Cerubidine
    Dosage: 60 mg/m2, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-05-22
    End date: 2010-05-24

Cytarabine
    Dosage: 200 mg/m2, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-05-22
    End date: 2010-05-22



Possible Cerubidine side effects in 31 year old male

Reported by a physician from France on 2011-10-11

Patient: 31 year old male

Reactions: Escherichia Sepsis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 400 g, 1x/day
    Indication: Leukaemia
    Start date: 2008-11-17
    End date: 2008-11-23

Cerubidine
    Dosage: 120 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-11-17
    End date: 2008-11-19

Gemtuzumab Ozogamicin
    Dosage: 12 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-11-20
    End date: 2008-11-20



Possible Cerubidine side effects in 56 year old male

Reported by a physician from France on 2011-10-04

Patient: 56 year old male

Reactions: Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg/m2, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-19

Gemtuzumab Ozogamicin
    Dosage: 6 mg/m2, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-16
    End date: 2010-08-16

Cerubidine
    Dosage: 60 mg/m2, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-15

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017